GlassScriptPhysician profile
Michael Oszczakiewicz
NPI 1134239387
$7,748.93
in general payments reported to CMS, 2019-2025
35 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $1,545 · 2021: $487 · 2022: $1,282 · 2023: $1,200 · 2024: $1,465 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,681.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $2,000.14 | 2020-2024 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Edwards Lifesciences Corporation | $1,866.02 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve |
| W. L. Gore & Associates, INC. | $429.06 | 2019-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Abbott Laboratories | $421.10 | 2021-2024 | Epic |
| Abiomed | $286.77 | 2023-2025 | Impella |
| Ethicon US, LLC | $283.61 | 2019-2025 | Evarrest, Enseal, Surgicel Nu-Knit |
| Silk Road Medical, INC. | $265.19 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $256.67 | 2021-2025 | Endurant Iis, Penditure, Invos |
| Medtronic Vascular, INC. | $251.95 | 2019-2020 | |
| Stryker Corporation | $247.64 | 2020-2025 | Flowtriever, Artix Mt |
| Musculoskeletal Transplant Foundation INC. | $207.49 | 2020 | |
| Atricure, INC. | $167.45 | 2021-2024 | |
| Boston Scientific Corporation | $158.78 | 2023-2025 | Lux-Dx Insertable Cardiac Monitor, Ingevity+ |
| Clearflow INC. | $121.17 | 2023 | Pleuraflow System With Flowglide |
| Smith+Nephew, INC. | $100.81 | 2022-2025 | Pico 7, Collagenase Santyl |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hemosonics LLC | $83.43 | 2020 | |
| Becton, Dickinson and Company | $82.90 | 2024 | Phasix Mesh |
| Livanova USA, INC. | $80.42 | 2019 | |
| Lsi Solutions INC | $60.63 | 2022 | |
| Nuwellis, INC. | $55.61 | 2024-2025 | Aquadex Smartflow Console |
| Kls-Martin L.P. | $35.73 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $34.87 | 2022-2023 | Exparel |
| Depuy Synthes Sales INC. | $32.78 | 2019 | |
| Janssen Pharmaceuticals, INC | $31.65 | 2019-2021 | |
| Wound Management Technologies, INC | $26.75 | 2019 | |
| Medinc of Texas | $24.38 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $22.62 | 2023 | Imfinzi |
| Cook Medical LLC | $21.32 | 2019 | |
| Admedus Corporation | $19.75 | 2019 | |
| Sanara Medtech INC. | $14.93 | 2023 | Celleraterx |
| Acell, INC. | $14.44 | 2019 | |
| Davol INC. | $12.60 | 2020 | |
| Convatec INC. | $11.82 | 2020 | |
| Kerecis Limited | $10.61 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Biomerieux INC | $7.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Oszczakiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.